Russell Investments Group Ltd. Sells 5,356 Shares of Teleflex Incorporated (NYSE:TFX)

Russell Investments Group Ltd. lessened its holdings in Teleflex Incorporated (NYSE:TFX - Free Report) by 24.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 16,268 shares of the medical technology company's stock after selling 5,356 shares during the quarter. Russell Investments Group Ltd.'s holdings in Teleflex were worth $4,058,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Allworth Financial LP increased its position in Teleflex by 332.3% during the 3rd quarter. Allworth Financial LP now owns 134 shares of the medical technology company's stock valued at $26,000 after purchasing an additional 103 shares during the period. Lindbrook Capital LLC grew its position in shares of Teleflex by 75.3% during the 4th quarter. Lindbrook Capital LLC now owns 135 shares of the medical technology company's stock worth $34,000 after buying an additional 58 shares during the period. Venturi Wealth Management LLC acquired a new stake in shares of Teleflex during the 3rd quarter worth approximately $27,000. Massmutual Trust Co. FSB ADV grew its position in shares of Teleflex by 418.5% during the 4th quarter. Massmutual Trust Co. FSB ADV now owns 140 shares of the medical technology company's stock worth $35,000 after buying an additional 113 shares during the period. Finally, Covestor Ltd grew its position in shares of Teleflex by 305.6% during the 3rd quarter. Covestor Ltd now owns 146 shares of the medical technology company's stock worth $29,000 after buying an additional 110 shares during the period. Institutional investors own 95.62% of the company's stock.

Teleflex Stock Down 0.4 %

TFX traded down $0.77 during mid-day trading on Friday, reaching $203.93. 316,507 shares of the stock were exchanged, compared to its average volume of 391,058. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.41 and a current ratio of 2.51. The stock has a market capitalization of $9.61 billion, a PE ratio of 32.73, a price-to-earnings-growth ratio of 1.99 and a beta of 1.13. The company has a 50 day moving average price of $215.01 and a two-hundred day moving average price of $226.55. Teleflex Incorporated has a 1 year low of $177.63 and a 1 year high of $262.97.

Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings data on Thursday, May 2nd. The medical technology company reported $3.21 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.07 by $0.14. The firm had revenue of $737.80 million for the quarter, compared to the consensus estimate of $726.85 million. Teleflex had a net margin of 9.82% and a return on equity of 14.78%. The business's revenue for the quarter was up 3.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $3.09 EPS. As a group, research analysts anticipate that Teleflex Incorporated will post 13.72 EPS for the current year.

Teleflex Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, June 14th. Investors of record on Wednesday, May 15th will be issued a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.67%. The ex-dividend date of this dividend is Tuesday, May 14th. Teleflex's dividend payout ratio (DPR) is currently 21.83%.

Analysts Set New Price Targets

Several analysts have recently commented on TFX shares. Truist Financial reduced their price objective on shares of Teleflex from $240.00 to $219.00 and set a "hold" rating for the company in a research report on Friday, May 3rd. Needham & Company LLC reiterated a "hold" rating on shares of Teleflex in a report on Friday, May 3rd. StockNews.com cut Teleflex from a "buy" rating to a "hold" rating in a report on Friday, February 23rd. JMP Securities reiterated a "market outperform" rating and issued a $285.00 target price on shares of Teleflex in a report on Friday, February 23rd. Finally, Royal Bank of Canada cut their target price on Teleflex from $272.00 to $265.00 and set an "outperform" rating on the stock in a report on Friday, February 23rd. Four investment analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. According to data from MarketBeat.com, Teleflex presently has an average rating of "Moderate Buy" and an average price target of $261.75.

Insider Buying and Selling

In related news, VP Cameron P. Hicks sold 7,401 shares of the business's stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $225.00, for a total value of $1,665,225.00. Following the transaction, the vice president now directly owns 10,050 shares of the company's stock, valued at approximately $2,261,250. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 1.43% of the stock is owned by insiders.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.